Medtech and pharma companies continue to support Ukraine relief efforts following Russia’s invasion. Previously, the World Health Organization announced that it was sending “essential medical supplies” to Ukraine — including its first shipment of 36 metric tons of supplies for trauma care and emergency surgery and other health supplies — to meet the needs of more than…
Owen Mumford starts work on new production center in U.K.
Owen Mumford this week announced that it has started building its new production facility in Witney, Oxfordshire in the U.K. Owen Mumford’s new Witney facility will stand as a production site for the company’s recently launched, next-generation auto-injector Aidaptus. The company has decades of experience creating its own drug delivery, blood sampling and rapid diagnostic products…
Moderna sales increase 64 times in Q2
Moderna (NSDQ:MRNA) posted second-quarter results today that beat the overall consensus on Wall Street. The Cambridge, Mass.–based company reported profits of $2.8 billion, or $6.46 per share, on sales of $4.4 billion for the three months ended June 30 for a sales growth of 6,398.51% compared with Q2 2020. Earnings per share were $6.46, 40¢ ahead…
Moderna sales increase 242 times in Q1, says COVID-19 vaccine 96% effective in teens
Moderna (Nasdaq:MRNA) posted first-quarter results today that beat the earnings consensus on Wall Street but slightly missed on revenue estimates. The company reported profits of $1.2 billion, or $2.84 per share, on sales of $1.9 billion for the three months ended March 31, for a sales growth of 24112% compared with Q1 2020. Earnings per…
JanOne selects partner to bottle its PAD drug
JanOne recently announced that it has forged a partnership with a company to bottle and label its JAN101 drug. JanOne said it is preparing its investigational new drug application for FDA submission as a potential treatment for vascular complications caused by COVID-19. The drug is already planned for use in Phase 2b trials as a…